New

Global ETF Survey 2026: Answer now →

Help us improve your experience. Please confirm your investor type:

Global ETF Survey 2026

The ETF Industry Is Evolving Fast

From AI infrastructure to active strategies, the ETF landscape is shifting. Share your perspective in the 7th Annual Global ETF Survey.

Global ETF Survey 2026
›ETF Issuers›First Trust›FBT
FBT

First Trust NYSE Arca Biotechnology ETF

Passive ETFEquity
Not rated

The FBT Exchange Traded Fund (ETF) is provided by First Trust. It is built to track an index: NYSE Arca Biotechnology Index. This share class generates a stream of income by distributing dividends.

Advertisement

Advertisement

Diversification
Data as of 05/31/26
No. of holdings
30
Effective diversification
28.8
Total weight of top 15 holdings
57.82%
Top 15 Holdings
Data as of 05/31/26
Corcept Therapeutics, Inc.
5.10%
Bruker Corp.
4.71%
Veracyte, Inc.
4.70%
Illumina, Inc.
4.12%
NeoGenomics, Inc.
4.12%
Axsome Therapeutics, Inc.
3.92%
Alkermes Plc
3.84%
Neurocrine Biosciences, Inc.
3.79%
Arrowhead Pharmaceuticals, Inc.
3.50%
Krystal Biotech, Inc.
3.49%
Exelixis, Inc.
3.44%
Natera, Inc.
3.44%
Biogen, Inc.
3.37%
argenx SE
3.17%
Repligen Corp.
3.11%
Sector exposures
Data as of 05/31/26
Healthcare
020%40%60%80%100%
Country exposures
Data as of 05/31/26
USA
Ireland
Netherlands
Germany
Switzerland
Denmark
020%40%60%80%90%

Trackinsight
Essentials

A forever free toolbox for fund selection, analysis, research, and ETF portfolio construction.

Essential free account includes:
  • More fund data
  • Compare up to 3 funds
  • More screener filters
  • Edit screener columns from 100+ metrics
  • Watchlists for saving your research
  • Portfolio construction and analysis
  • Personal dashboard for live monitoring

Advertisement

Trackinsight

About Trackinsight

Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.

Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.

In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.

This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.

Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.

More about Trackinsight
ETF TOOLS
ETF ScreenerCompare ETFsCompare ETF issuersWatchlistsETF Portfolio InsightsIndustry dataETF stock exposure finder
PLATFORM
Support and feedback
ETF NEWS & RESEARCH
Latest ETF NewsETF Research ReportsGlobal ETF Survey 2025Learn ETF investing
PROFESSIONAL SOLUTIONS
Enterprise SolutionsDue Diligence ServicesETF Data Services
SOLUTIONS FOR
Institutional investorsPrivate banksFinancial advisorsFintech and mediaIndividual investors
CONTACT US
General inquiries
Press and media
Advertising opportunities
Support and feedback
© 2014-2026 Trackinsight SA. All rights reserved.
Privacy policy  |  Cookie policy  |    |  Terms of use  |  Imprint
Get our newsletters
Trackinsight